SKI Market

A+| A| A-|

Indian Indices

Sensex

76,070.84 567.99
( 0.75%)

Global Indices

Nasdaq

46,970.79 391.31
(0.84%)

Dow Jones

6,721.52 68.33
(1.03%)

Hang Seng

53,528.27 -222.88
(-0.41%)

Nikkei 225

10,406.71 89.02
(0.86%)

Forex

USD-INR

92.32 0.03
(0.03%)

EUR-INR

105.40 -1.04
(-0.98%)

GBP-INR

122.05 -1.31
(-1.06%)

JPY-INR

0.58 0.00
(-0.37%)

YOU ARE HERE :
HOME
Markets
Equity
Company News

EQUITY - MARKET SCREENER

Divis Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

532488

INE361B01024

578.2640535

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DIVISLAB

62.69

161269.51

EPS(TTM)

Face Value()

Div & Yield %

96.91

0.49

Date	Headline
11-Feb-2026	Divi's Laboratories consolidated net profit declines 1.02% in the December 2025 quarter
30-Jan-2026	Divis Laboratories schedules board meeting
19-Jan-2026	Divis Laboratories Ltd drops for fifth straight session
03-Dec-2025	Divis Laboratories Ltd eases for fifth straight session
07-Nov-2025	Divi's Laboratories standalone net profit rises 34.36% in the September 2025 quarter
07-Nov-2025	Divi's Laboratories consolidated net profit rises 35.10% in the September 2025 quarter
07-Nov-2025	Divis Laboratories Ltd - Divis Laboratories Limited - Appointment
07-Nov-2025	Divis Laboratories Ltd - Divis Laboratories Limited - Outcome of Board Meeting
28-Oct-2025	Divis Laboratories to announce Quarterly Result
17-Oct-2025	Divis Laboratories Ltd - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

<< < 1 2 > >>

76,070.84 567.99 ( 0.75%)

46,970.79 391.31 (0.84%)

6,721.52 68.33 (1.03%)

53,528.27 -222.88 (-0.41%)

10,406.71 89.02 (0.86%)

92.32 0.03 (0.03%)

105.40 -1.04 (-0.98%)

122.05 -1.31 (-1.06%)

0.58 0.00 (-0.37%)